Todralazine (hydrochloride)

Todralazine hydrochloride (Ecarazine hydrochloride) is an anti-hypertensive agent, acts as a β2AR blocker, with antioxidant and free radical scavenging activity[1].

Product Specifications

CAS Number

[3778-76-5]

Product Name Alternative

Ecarazine (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302-H312-H332

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/todralazine-hydrochloride.html

Purity

99.87

Solubility

DMSO : 125 mg/mL (ultrasonic) |H2O : 14.29 mg/mL (ultrasonic)

Smiles

O=C(NNC1=NN=CC2=C1C=CC=C2)OCC.[H]Cl

Molecular Formula

C11H13ClN4O2

Molecular Weight

268.70

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P501

References & Citations

[1]Dimri M, et al. Todralazine protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansion. Zebrafish. 2015 Feb;12 (1) :33-47.